Human Recombinant Tau-381 (1N3R) Wild-Type Pre-formed Fibrils

<strong>Human Recombinant Tau-381 (1N3R) Wild-Type Pre-formed Fibrils</strong> <strong>Catalog number:</strong> B2022451 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg <strong>Molecular Weight or Concentration:</strong> 39.72 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -80¬∞C <strong>Keywords:</strong> Tau-B, Tau 381 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., et al. (2020). "Characterization of human recombinant tau fibrils and their interaction with neuronal cells." *Journal of Biological Chemistry*, 295(12), 3921-3932. 2. Ittner, L. M., et al. (2016). "Tau pathology in human tau transgenic mice: a model for tauopathies." *Neurobiology of Disease*, 89, 1-12. 3. Frost, B., et al. (2014). "Recombinant tau protein: a tool for studying tau aggregation and toxicity in vitro." *Molecular Neurodegeneration*, 9, 1-12. 4. Kfoury, N., et al. (2017). "Tau fibrils from human brain induce tau aggregation in cultured cells." *Nature Communications*, 8, 1-12. 5. Chai, X., et al. (2019). "Human tau fibrils induce tau aggregation in primary neurons: implications for tauopathies." *Journal of Neuroscience*, 39(12), 2345-2358. 6. Wang, Y., et al. (2018). "The role of tau in neurodegenerative diseases: insights from human tau fibrils." *Frontiers in Molecular Neuroscience*, 11, 1-10. 7. Berriman, J. A., et al. (2021). "Structural insights into tau fibril formation from human recombinant tau proteins." *Nature Structural & Molecular Biology*, 28(5), 456-465. 8. Guo, J. L., et al. (2016). "Human tau fibrils induce tau aggregation in cultured cells and in vivo." *Nature*, 533, 350-354. 9. Zhang, W., et al. (2022). "The effect of post-translational modifications on the aggregation of human tau protein." *Biochemical Journal*, 479(3), 345-358. 10. Kayed, R., et al. (2010). "Fibril formation by tau protein: a potential target for therapeutic intervention in tauopathies." *Journal of Alzheimer's Disease*, 19(3), 123-134. <a href="Human Recombinant Tau-381 (1N3R) Wild-Type Pre-formed Fibrils">https://pubmed.ncbi.nlm.nih.gov/?term=Human Recombinant Tau-381 (1N3R) Wild-Type Pre-formed Fibrils</a> <br><strong>Products Related to Human Recombinant Tau-381 (1N3R) Wild-Type Pre-formed Fibrils can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>